M S Nieminen

Summary

Affiliation: Helsinki University Central Hospital
Country: Finland

Publications

  1. ncbi Effect of treating periodontitis on C-reactive protein levels: a pilot study
    Kimmo Mattila
    Department of Medicine, Divisions of Infectious Diseases and Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    BMC Infect Dis 2:30. 2002
  2. ncbi Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II
    Markku S Nieminen
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Finland
    Eur J Heart Fail 10:140-8. 2008
  3. ncbi Oral levosimendan in patients with severe chronic heart failure --the PERSIST study
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Eur J Heart Fail 10:1246-54. 2008
  4. ncbi Levosimendan compared with dobutamine in low output patients
    M S Nieminen
    Division of Cardiology, University Central Hospital, Helsinki, Finland
    Minerva Anestesiol 69:258-63. 2003
  5. ncbi Considerations on the efficacy and safety of levosimendan in ischemic heart failure
    Markku S Nieminen
    Division of Cardiology, University Central Hospital, 00290 Helsinki, Finland
    Ital Heart J 4:39S-44S. 2003
  6. ncbi EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
    Markku S Nieminen
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, PO Box 340, 00029 HUS, Finland
    Eur Heart J 27:2725-36. 2006
  7. ncbi Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure
    M S Nieminen
    Helsinki University, Finland
    J Am Coll Cardiol 36:1903-12. 2000
  8. ncbi Definition and epidemiology of acute heart failure syndromes
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Am J Cardiol 96:5G-10G. 2005
  9. ncbi Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
    Eur Heart J 26:384-416. 2005
  10. ncbi [Diagnosis and treatment of acute heart failure. Guidelines of the European Society of Cardiology]
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
    Kardiol Pol 63:143-86; discussion 187-9. 2005

Detail Information

Publications114 found, 100 shown here

  1. ncbi Effect of treating periodontitis on C-reactive protein levels: a pilot study
    Kimmo Mattila
    Department of Medicine, Divisions of Infectious Diseases and Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    BMC Infect Dis 2:30. 2002
    ..We wanted to study if treatment of periodontitis can decrease the levels of these inflammatory markers...
  2. ncbi Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II
    Markku S Nieminen
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Finland
    Eur J Heart Fail 10:140-8. 2008
    ..This analysis evaluates the gender differences in patients hospitalised for acute heart failure (AHF) in the EuroHeart Failure Survey II (EHFS)...
  3. ncbi Oral levosimendan in patients with severe chronic heart failure --the PERSIST study
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Eur J Heart Fail 10:1246-54. 2008
    ..Intravenous levosimendan improves symptoms in acutely decompensated heart failure...
  4. ncbi Levosimendan compared with dobutamine in low output patients
    M S Nieminen
    Division of Cardiology, University Central Hospital, Helsinki, Finland
    Minerva Anestesiol 69:258-63. 2003
    ..Levosimendan produced haemodynamic responses that were unaffected by concomitant use of beta blockers...
  5. ncbi Considerations on the efficacy and safety of levosimendan in ischemic heart failure
    Markku S Nieminen
    Division of Cardiology, University Central Hospital, 00290 Helsinki, Finland
    Ital Heart J 4:39S-44S. 2003
    ..No increase in arrhythmias is seen. The hemodynamic effects of levosimendan are dose-dependent and the current recommended doses are safe. No increase in mortality or any life-threatening arrhythmias have been observed...
  6. ncbi EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
    Markku S Nieminen
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, PO Box 340, 00029 HUS, Finland
    Eur Heart J 27:2725-36. 2006
    ....
  7. ncbi Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure
    M S Nieminen
    Helsinki University, Finland
    J Am Coll Cardiol 36:1903-12. 2000
    ..We sought to define the therapeutic dose range of levosimendan in patients with New York Heart Association class II-IV heart failure of ischemic origin...
  8. ncbi Definition and epidemiology of acute heart failure syndromes
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Am J Cardiol 96:5G-10G. 2005
    ..The epidemiology of AHFS has been studied in large and small registries and surveys in both North America and Europe. The properties of the population of patients with acute HF are discussed in light of these data...
  9. ncbi Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
    Eur Heart J 26:384-416. 2005
  10. ncbi [Diagnosis and treatment of acute heart failure. Guidelines of the European Society of Cardiology]
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
    Kardiol Pol 63:143-86; discussion 187-9. 2005
  11. ncbi Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol
    M Syvanne
    Department of Medicine, Helsinki University Central Hospital, Helsinki, Findland
    Circulation 98:1993-9. 1998
    ....
  12. ncbi Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects
    M Syvanne
    Department of Medicine, Helsinki University Central Hospital, Finland
    Coron Artery Dis 12:99-106. 2001
    ....
  13. ncbi Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events
    Anil Palikhe
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Am J Cardiol 99:890-5. 2007
    ..The relative increase in serum C3 protein and decrease in C4 protein could explain changes in the C3/C4 ratio...
  14. ncbi The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study
    Juhani Rossinen
    Divisions of Emergency Care and Cardiology Department of Internal Medicine, Helsinki, Finland
    Acute Card Care 10:209-13. 2008
    ..Although weakly supported by scientific evidence, according to guidelines the use of inotropes in acute heart failure is indicated in the presence of hypoperfusion refractory to fluid resuscitation...
  15. ncbi Endothelial release of tissue-type plasminogen activator and ischemia-induced vasodilatation are linked in patients with coronary heart disease
    J Sinisalo
    Department of Medicine, Helsinki University Central Hospital, Finland
    Blood Coagul Fibrinolysis 10:181-7. 1999
    ....
  16. ncbi The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production
    J Sinisalo
    Department of Medicine, Helsinki University Central Hospital, Finland
    J Antimicrob Chemother 41:85-92. 1998
    ..Thus extended doxycycline therapy did not affect C. pneumoniae antibodies or coronary heart disease risk factors. We conclude that doxycycline monotherapy may not be sufficient to eradicate chronic C. pneumoniae infection...
  17. ncbi Heart rate variability and progression of coronary atherosclerosis
    H V Huikuri
    Division of Cardiology, Department of Medicine and Biocenter of Oulu, University of Oulu, Finland
    Arterioscler Thromb Vasc Biol 19:1979-85. 1999
    ..HR variability provided information on progression of focal coronary atherosclerosis beyond that obtained by traditional risk markers of atherosclerosis...
  18. ncbi Multifactorial cardiovascular disease prevention in patients aged 75 years and older: A randomized controlled trial: Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study
    T E Strandberg
    Department of Medicine, Geriatric Clinic, and the Division of Cardiology, University of Helsinki, Helsinki, Finland
    Am Heart J 142:945-51. 2001
    ..The aim of the Drug and Evidence Based Medicine in the Elderly (DEBATE) study is to test the applicability and effectiveness of established CVD treatments in elderly patients...
  19. ncbi Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome
    Johan P E Lassus
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Eur Heart J 31:2791-8. 2010
    ..However, definitions and prognostic impact of AKI in AHF have been variable. Cystatin C is a prospective new marker of AKI. The objective of this study was to investigate the use of cystatin C as a marker of early AKI in AHF...
  20. ncbi Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome
    J P E Lassus
    Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Biomarkers 16:302-10. 2011
    ..We evaluated the interactions between kidney function, cardiac stress, and various inflammatory cytokines in patients with acute heart failure (AHF). The effect on 1-year mortality was also assessed...
  21. ncbi Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis
    Susanna Paju
    Institute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland
    Atherosclerosis 188:412-9. 2006
    ..Long-term clarithromycin therapy seems to be beneficial in prevention of recurrent cardiovascular events in non-periodontitis but not in periodontitis patients...
  22. ncbi Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy
    Satu Kärkkäinen
    Department of Medicine, Kuopio University Hospital, P O Box 1777, 70211 Kuopio, Finland
    Eur J Heart Fail 6:861-8. 2004
    ..Dilated cardiomyopathy (DCM) is familial in approximately 20-35% of cases of idiopathic DCM. Several mutations in the different sarcomere protein genes have been reported to cause DCM...
  23. ncbi Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction
    L Oikarinen
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    J Hypertens 19:1883-91. 2001
    ..We assessed the relation of QT intervals and QT dispersion to echocardiographically determined left ventricular (LV) mass and geometry in a large population of hypertensive patients with ECG evidence of LVH...
  24. ncbi Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes
    K Luotola
    Department of Medicine, Helsinki University Hospital, Helsinki, Finland
    J Intern Med 269:322-32. 2011
    ..We further examined whether genetic variants at the interleukin-1 (IL-1) locus would predict clinically incident diabetes...
  25. ncbi The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure
    V P Harjola
    Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Int J Clin Pharmacol Ther 46:389-99. 2008
    ..The aim of this exploratory study was to assess the hemodynamic and pharmacokinetic interactions between digoxin and oral levosimendan as well as the proarrhythmic potential of this combination in patients with chronic heart failure...
  26. ncbi Serum homocysteine, creatinine, and glucose as predictors of the severity and extent of coronary artery disease in asymptomatic members of high-risk families
    P Pajunen
    Hilsinki University Central Hospotal, Helsinki, Finland
    Eur J Clin Invest 32:472-8. 2002
    ..There has been no previous study to determine the severity and extent of coronary artery disease (CAD) in subjects with no diagnosis or symptoms of CAD at the time of the angiography...
  27. ncbi Biodegradation of the copolymeric polylactide stent. Long-term follow-up in a rabbit aorta model
    E M Hietala
    Department of Surgery, Helsinki University Hospital, Helsinki, Finland
    J Vasc Res 38:361-9. 2001
    ..PLA96 may thus be a promising stent core material for small vessels in the future, although further investigation is needed to establish its final biocompatibility...
  28. ncbi Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease
    M Graner
    Helsinki University Central Hospital, Helsinki, Finland
    Eur J Clin Invest 36:764-70. 2006
    ....
  29. ncbi Clinical findings, outcome and treatment in patients > or = 75 years with acute myocardial infarction
    Mervi Kotamäki
    Department of Medicine, Division of Cardiology, University of Helsinki, Finland
    Eur J Epidemiol 18:781-6. 2003
    ..Our aim was to characterize current clinical course, medication and invasive treatment in elderly patients with AMI, compare treatment between sexes and also with data from 1994...
  30. ncbi Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease
    Marit Graner
    Department of Internal Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Ann Med 39:137-44. 2007
    ..Insulin resistance (IR) is frequently observed in patients with coronary artery disease (CAD). Aim. To examine the association between IR and severity and extent of CAD...
  31. ncbi Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis
    Mikko Syvanne
    Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, P O Box 340, Haartmaninkatu 4, Helsinki, 00029 HUS, Finland
    Atherosclerosis 172:267-72. 2004
    ..The MTHFR genotype was not associated with extent or progression of coronary atherosclerosis. We conclude that gemfibrozil causes a significant elevation in tHcy levels, but the clinical relevance of this is unknown at present...
  32. ncbi Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease
    Marit Graner
    Department of Internal Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    J Am Coll Cardiol 47:2429-35. 2006
    ..The goal of this study was to examine the association between paraoxonase-1 (PON1) activity and concentration and the severity and extent of coronary artery disease (CAD)...
  33. ncbi Clinical usefulness of bronchoalveolar lavage in heart transplant recipients with suspected lower respiratory tract infection
    Juho T Lehto
    Respiratory Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    J Heart Lung Transplant 23:570-6. 2004
    ..In this study, we evaluated the clinical impact and safety of bronchoscopy with BAL in heart transplant recipients...
  34. ncbi Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP
    Johan Lassus
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, POB 340, 00029 HUS, Helsinki, Finland
    Eur Heart J 28:1841-7. 2007
    ..We investigated the prognostic value of cystatin C in acute heart failure (AHF) in comparison to other markers of renal function and NT-proBNP...
  35. ncbi Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events
    Peter M Okin
    Department of Medicine, Division of Cardiology, Cornell University Medical Center, New York, NY 10021, USA
    JAMA 292:2343-9. 2004
    ..However, the predictive value of changes in the magnitude of electrocardiographic LVH criteria during antihypertensive therapy remains unclear...
  36. ncbi Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure
    Veli Pekka Harjola
    Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, PO Box 340, Helsinki 00029 HUS, Finland
    Eur J Heart Fail 12:239-48. 2010
    ..Acute heart failure (AHF) has a poor prognosis. We evaluated 3- and 12-month mortality in different clinical classes of AHF patients from 30 European countries who were included in the EuroHeart Failure Survey (EHFS) II...
  37. ncbi Stimulated release of endothelin-converting enzyme is simultaneous with tissue-type plasminogen activator and decrease in coronary heart disease
    Juha Sinisalo
    Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Scand Cardiovasc J 36:100-4. 2002
    ..We examined whether shedding of endothelin-converting enzyme (ECE), a metalloprotease responsible for endothelin production, is concomitant with tissue-type plasminogen activator (t-PA), and how atherosclerosis affects ECE release...
  38. ncbi Possibilities of multifactorial cardiovascular disease prevention in patients aged 75 and older: a randomized controlled trial: Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study
    Timo E Strandberg
    Department of Medicine, Geriatric Clinic and Division of Cardiology, University of Helsinki, Helsinki, Finland
    Eur Heart J 24:1216-22. 2003
    ..The aim of this pre-planned, first-year analysis of the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) Study was to determine the feasibility of prevention efforts in elderly cardiovascular patients...
  39. ncbi Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease
    Marit Graner
    Department of Internal Medicine, Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, FIN 00290 HUCH, Helsinki, Finland
    Nutr Metab Cardiovasc Dis 18:271-7. 2008
    ..Therefore, the aim of the present study was to examine the association between apoE polymorphism and carotid intima-media thickness (IMT), and severity and extent of coronary artery disease (CAD)...
  40. ncbi Predictive value of electrocardiographic QT interval and T-wave morphology parameters for all-cause and cardiovascular mortality in a general population sample
    Kimmo Porthan
    Department of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Heart Rhythm 6:1202-8, 1208.e1. 2009
    ..The predictive value of ECG QT interval for mortality in the general population has been weak. Only a few population studies on the predictive value of ECG T-wave morphology parameters for mortality have been reported...
  41. ncbi Cardiac findings of reactive arthritis: an observational echocardiographic study
    Timo Hannu
    Department of Medicine, Helsinki University Central Hospital, HUCH, Finland
    Rheumatol Int 21:169-72. 2002
    ..Echocardiographic evaluation may be warranted if the acute ReA persists or has a prolonged course but is not recommended for routine use...
  42. ncbi High prevalence of four long QT syndrome founder mutations in the Finnish population
    Annukka Marjamaa
    Research Program in Molecular Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    Ann Med 41:234-40. 2009
    ..In the present survey, we sought to estimate the actual prevalence of the founder mutations and to determine their effect sizes in the general Finnish population...
  43. ncbi Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome
    Juha Sinisalo
    Helsinki University Central Hospital, Department of Medicine, Division of Cardiology, Finland
    Circulation 105:1555-60. 2002
    ..Coronary artery disease, an inflammatory disease, may be caused by infection. We investigated whether the antibiotic clarithromycin would reduce morbidity and mortality in patients with acute non-Q-wave coronary syndrome...
  44. ncbi Late fields of the magnetocardiographic QRS complex as indicators of propensity to sustained ventricular tachycardia after myocardial infarction
    P Korhonen
    Division of Cardiology and the BioMag Laboratory, Helsinki University Central Hospital, Finland
    J Cardiovasc Electrophysiol 11:413-20. 2000
    ..Magnetocardiographic (MCG) mapping is a new method to record cardiac signals. This study examined the association of MCG late fields with the propensity to sustained ventricular tachycardia (VT) after myocardial infarction (MI)...
  45. ncbi Effect of age and body weight on neurohumoral variables in healthy Cavalier King Charles spaniels
    A S Eriksson
    Department of Clinical Veterinary Sciences, Faculty of Veterinary Medicine, Helsinki University, Finland
    Am J Vet Res 62:1818-24. 2001
    ..The increased plasma concentrations of NT-ANP (but not BNP) and P-NN with aging reflect neurohumoral physiologic changes that must be distinguished from pathologic changes in patients with heart failure...
  46. ncbi Periodontopathogen- and host-derived immune response in acute coronary syndrome
    H Alfakry
    Institute of Dentistry, University of Helsinki, Helsinki, Finland
    Scand J Immunol 74:383-9. 2011
    ..Despite the observed cross-reactivity in the systemic IgG-class antibody response to HSP60 and A. actinomycetemcomitans, the pathogen carriage in saliva or the periodontal status did not affect the HSP60 antibody levels in ACS patients...
  47. ncbi Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure
    Kati H Miettinen
    Department of Medicine, Kuopio University Hospital, Kuopio, Finland
    Eur J Heart Fail 10:396-403. 2008
    ..Cytokines play an important role in chronic heart failure (HF), but little is known about their involvement in acute decompensated heart failure (ADHF)...
  48. ncbi Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME Study
    Teemu Niiranen
    Department of Health and Functional Capacity, National Public Health Institute, Helsinki, Finland
    J Hypertens 25:1225-31. 2007
    ..Other risk factors associated with carotid atherosclerosis were also investigated...
  49. ncbi Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy
    Frej Fyhrquist
    Helsinki University Central Hospital, Department of Medicine, and Minerva Institute for Medical Research, Helsinki, Finland
    Hypertension 45:580-5. 2005
    ..The risks in the losartan group also increased with increasing pulse pressure quartile, but were lower than those in the atenolol group, and were not significant...
  50. ncbi Effects of levosimendan on the energy balance: preclinical and clinical evidence
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    J Cardiovasc Pharmacol 53:302-10. 2009
    ..Moreover, levosimendan-evoked KATP channel opening may possess favorable effects on mitochondrial adenosine triphosphate synthesis conferring cardioprotection during ischemic insults...
  51. ncbi Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer
    M Hedman
    Department of Medicine, Kuopio University Hospital, Kuopio, Finland
    Gene Ther 16:629-34. 2009
    ..85), cancer (1 vs 4 vs 2; P=0.38) or diabetes (2 vs 2 vs 2; P=0.97) did not differ between the groups. Local intracoronary VEGF gene transfer is safe and does not increase the risk of MACE, arrhythmias, cancer, diabetes or other diseases...
  52. ncbi Relation of inflammation to vascular function in patients with coronary heart disease
    J Sinisalo
    Department of Medicine, Division of Cardiology, The Helsinki University Central Hospital, Meilahti 15krs, Haartmaninkatu 4, FIN 00290, Helsinki, Finland
    Atherosclerosis 149:403-11. 2000
    ..It is possible that endothelial dysfunction in coronary heart disease patients is related to the chronic inflammation or infection coexisting with atherosclerosis...
  53. ncbi QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study
    Lasse Oikarinen
    Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
    Hypertension 43:1029-34. 2004
    ....
  54. ncbi Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men
    Kimmo Porthan
    Helsinki University Central Hospital, Helsinki, Finland
    Ann Med 41:29-37. 2009
    ..Hypertension-induced left ventricular structural remodelling associates with repolarization abnormalities. We investigated if antihypertensive drugs can modulate ventricular repolarization...
  55. ncbi [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]
    Markku S Nieminen
    Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland. markku.nieminen.hus.fi
    Rev Esp Cardiol 58:389-429. 2005
  56. ncbi Common candidate gene variants are associated with QT interval duration in the general population
    A Marjamaa
    Research Program in Molecular Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    J Intern Med 265:448-58. 2009
    ..As 30-40% of the QT-interval variability is heritable, we tested the association of common LQTS and NOS1AP gene variants with QT interval in a Finnish population-based sample...
  57. ncbi Heart transplantation in repaired transposition of the great arteries
    A L Harjula
    Department of Thoracic and Cardiovascular Surgery, Helsinki University Central Hospital, Finland
    Ann Thorac Surg 46:611-4. 1988
    ..Six months after operation, the patient is doing better than ever before in his life. Our findings suggest that a complicated conotruncal development does not preclude cardiac transplantation...
  58. ncbi Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes
    P Pajunen
    Department of Medicine, Helsinki University Central Hospital, Finland
    Scand Cardiovasc J 35:96-100. 2001
    ..In the diabetic group this association was independent of LpA-I levels, suggesting impaired antiatherogenic potential of these particles in type 2 diabetic patients...
  59. ncbi Effect of ibopamine on the failing heart at rest and during isometric exercise: a noninvasive study
    J Partanen
    First Department of Medicine, University Central Hospital, Helsinki, Finland
    Clin Cardiol 11:15-22. 1988
    ..Neither urine volume nor body weight changed. Side effects were mild except for tachycardia of one patient.(ABSTRACT TRUNCATED AT 250 WORDS)..
  60. ncbi Lymphotoxin alpha LTA+496C allele is a risk factor for periodontitis in patients with coronary artery disease
    A Palikhe
    Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Tissue Antigens 71:530-7. 2008
    ..56; 95% CI = 1.05-2.30; P = 0.026) remained as significant risk factors for periodontitis. In conclusion, the major finding of this study is that the LTA+496C allele is associated with periodontitis in patients with CAD...
  61. ncbi Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease
    A Palikhe
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Tissue Antigens 69:47-55. 2007
    ..46; 95% CI 0.24-0.88; P = 0.02) or together with the haplotype LTA+253a-LTA+633g-C4A3-C4B1 (OR 0.36; 95% CI 0.22-0.57; P = 0.00001). In conclusion, human MHC region harbors genes that protect from and predispose to CAD...
  62. ncbi Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study
    P M Okin
    Department of Medicine, Division of Cardiology, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Hum Hypertens 18:403-9. 2004
    ..Compared with progression of ECG LVH, regression of the Cornell product ECG LVH is associated with greater reduction in LV mass and a greater likelihood of regression of anatomic LVH...
  63. ncbi Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience
    Mika Lehto
    Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Eur Heart J 26:350-6. 2005
    ..The present study aimed to determine the frequency and the impact on clinical outcome of atrial fibrillation (AF) in patients with acute myocardial infarction (AMI) and left ventricular dysfunction...
  64. ncbi Relation of twelve-lead electrocardiographic T-wave morphology descriptors to left ventricular mass
    Lasse Oikarinen
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Am J Cardiol 90:1032-5. 2002
  65. ncbi Is periodontal infection behind the failure of antibiotics to prevent coronary events?
    Susanna Paju
    Institute of Dentistry, University of Helsinki and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, PO Box 63, 00014 Helsinki, Finland
    Atherosclerosis 193:193-5. 2007
    ..We discuss the systemic effects of periodontal infection and consider studies to test our hypothesis, which offers a novel viewpoint for discussion of antibiotics in coronary-disease prevention...
  66. ncbi Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study
    Lasse Oikarinen
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Am Heart J 145:919-25. 2003
    ..Experimentally, regression of LVH normalizes ventricular electrophysiology...
  67. ncbi Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum
    Anil Palikhe
    Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Scand J Infect Dis 41:201-5. 2009
    ..003). In conclusion, Chlamydia pneumoniae DNA is present during acute coronary syndrome and in the recovery period, but declines in stable state, suggesting a role of the bacterium in the acute phase of coronary syndrome...
  68. ncbi Relationship of electrocardiographic repolarization measures to echocardiographic left ventricular mass in men with hypertension
    Kimmo Porthan
    Department of Cardiology, Helsinki University Central Hospital, Finland
    J Hypertens 25:1951-7. 2007
    ..We studied whether electrocardiographic repolarization changes are already detectable in mild LVM increase associated with hypertension...
  69. ncbi Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies
    Riitta Paakkanen
    Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Scand Cardiovasc J 43:395-401. 2009
    ..We sought to examine the role of complement component C4 deficiencies on the effect of antibiotic treatment in patients with acute coronary syndrome (ACS)...
  70. ncbi Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular events
    K Markus Pelkonen
    Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    Blood Coagul Fibrinolysis 16:275-80. 2005
    ..In conclusion, lower PC and AT values, even within the normal range, seem to be associated with elevated risk for recurrent cardiovascular events and shorter event-free time in acute coronary syndrome patients...
  71. ncbi Electrocardiographic assessment of left ventricular hypertrophy with time-voltage QRS and QRST-wave areas
    L Oikarinen
    Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
    J Hum Hypertens 18:33-40. 2004
    ..732; P<0.001). In conclusion, the BSPM QRS area sum compared to 12-lead QRS area sum does not substantially improve LVH assessment. The 2-lead QRS area sum may improve ECG QRS area-based LVH assessment...
  72. ncbi Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study
    Vittorio Palmieri
    Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA
    Am J Hypertens 21:701-7. 2008
    ..In cross-sectional data in hypertensive subjects, brachial pulse pressure (PP)/Doppler stroke index (SVi), (PP/SVi) correlates weakly but significantly with left ventricular (LV) mass and relative wall thickness (RWT)...
  73. ncbi A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy
    Satu Kärkkäinen
    Department of Medicine, University of Kuopio, Kuopio University Hospital, P O Box 1777, 70211 Kuopio, Finland
    J Mol Med (Berl) 81:795-800. 2003
    ..We conclude that the desmin and delta-sarcoglycan genes are not predominant disease-causing genes in patients with DCM in eastern Finland...
  74. ncbi Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment
    Gerard P Aurigemma
    Department of Medicine, Division of Cardiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
    Am J Hypertens 16:180-6. 2003
    ..Accordingly, our aim was to study the relationship between prior treatment and both baseline and 1-year echocardiographic LV mass in subjects enrolled in the Losartan Intervention For Endpoint reduction (LIFE) study...
  75. ncbi Heart failure in the elderly: how risky is it to be discharged?
    Markku S Nieminen
    Eur J Heart Fail 10:222-3. 2008
  76. ncbi Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial
    Richard B Devereux
    Weill Medical College of Cornell University, New York, New York, USA
    Ann Intern Med 139:169-77. 2003
    ....
  77. ncbi Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene
    Philippa J Talmud
    Centre for Cardiovascular Genetics, Department of Medicine, British Heart Foundation Laboratories, Rayne Building, Royal Free and University College Medical School, 5 University St, London WC1E 6JF, UK
    Arterioscler Thromb Vasc Biol 23:644-9. 2003
    ..Alpha1-Antitrypsin (AAT) protects elastic tissue and may play a role in atherogenesis. The association of atherosclerosis progression with common AAT variants was considered in 2 clinical trials...
  78. ncbi Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study
    Peter M Okin
    Department of Medicine, Cornell University Medical Center, 525 East 68th St, New York, NY 10021, USA
    Circulation 108:684-90. 2003
    ..However, uncertainty persists as to how best to regress ECG LVH...
  79. ncbi Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis
    Nilesh J Samani
    Department of Cardiovascular Sciences, University of Leicester, UK
    Arterioscler Thromb Vasc Biol 28:1679-83. 2008
    ..The effect of the locus on early markers of atherosclerosis is unknown. We examined its association with carotid intima-media thickness (CIMT) and brachial flow-mediated dilatation (FMD)...
  80. ncbi Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study
    Kristian Wachtell
    Copenhagen County University Hospital, Glostrup, Denmark
    J Hypertens 20:405-12. 2002
    ....
  81. ncbi Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease
    David M Flavell
    Centre for Cardiovascular Genetics, Department of Medicine, Royal Free and University College of London Medical School, London, UK
    Circulation 105:1440-5. 2002
    ..Peroxisome proliferator-activated receptor alpha (PPARalpha) regulates the expression of genes involved in lipid metabolism and inflammation, making it a candidate gene for atherosclerosis and ischemic heart disease (IHD)...
  82. ncbi A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies
    Mohamed A Elrayess
    The Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free and University College Medical School, University College London, Rayne Building, 5 University Street, UK
    Atherosclerosis 168:131-8. 2003
    ..These data demonstrate that the PECAM-1 gene is responsive to shear stress in vitro and that decreased PECAM-1 gene expression in 53A carriers may influence reduced progression of vessel stenosis in patients with coronary artery disease...
  83. ncbi Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study
    Richard B Devereux
    Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    J Hypertens 20:1445-50. 2002
    ..To examine the time course of left ventricular (LV) geometric response to blood pressure (BP) control during 2 years of systematic antihypertensive treatment...
  84. ncbi Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint
    Peter M Okin
    Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    Am J Hypertens 15:663-71. 2002
    ..However, the high mortality associated with LVH in African American patients makes more accurate ECG detection of LVH in these patients a clinical priority...
  85. ncbi Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study
    Henrik M Reims
    Department of Cardiology, Ullevaal University Hospital, Oslo, Norway
    Blood Press 13:376-84. 2004
    ..Smoking increased cardiovascular risk markedly in the LIFE study. The benefit of losartan vs atenolol is consistent with the overall conclusion of the LIFE study, although the treatment effect appeared largest in non-smokers...
  86. ncbi Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
    Lars H Lindholm
    Steno Diabetes Centre, Gentofte, Denmark
    J Hypertens 20:1879-86. 2002
    ..There has been uncertainty about the risk of new-onset diabetes in hypertensive individuals treated with different blood pressure-decreasing drugs...
  87. ncbi Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy
    Sverre E Kjeldsen
    Department of Internal Medicine, Dividsion of Hypertension, University of Michigan, Ann Arbor, USA
    JAMA 288:1491-8. 2002
    ..046). Losartan decreased ECG-LVH more than atenolol (P<.001) and was better tolerated. CONCLUSION: These data suggest that losartan is superior to atenolol for treatment of patients with isolated systolic hypertension and ECG-LVH...
  88. ncbi Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study
    Peter M Okin
    Greenberg Division of Cardiology, Weill Medical College of Cornell University, New York, New York, USA
    Am J Hypertens 21:273-9. 2008
    ..Although albuminuria and the electrocardiographic (ECG) strain pattern each predict development of heart failure (HF), whether combining albuminuria and strain improves prediction of new HF is unclear...
  89. ncbi Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study
    Kristian Wachtell
    Department of Internal Medicine, Glostrup University Hospital, Glostrup, Denmark
    Circulation 116:700-5. 2007
    ..Sudden cardiac death (SCD) occurs more often in patients with ECG left ventricular (LV) hypertrophy. However, whether LV hypertrophy regression is associated with a reduced risk of SCD remains unclear...
  90. ncbi Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study
    Jorge R Kizer
    Weill Medical College of Cornell University, New York, NY, USA
    Hypertension 45:46-52. 2005
    ....
  91. ncbi Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study
    Kristian Wachtell
    Department of Medicine, Glostrup University Hospital, Glostrup, Denmark
    J Am Coll Cardiol 45:712-9. 2005
    ..This study was designed to evaluate whether different antihypertensive treatment regimens with similar blood pressure reduction have different effects on new-onset atrial fibrillation (AF)...
  92. ncbi Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study
    Peter M Okin
    Greenberg Division of Cardiology, Weill Medical College of Cornell University, New York, NY 10021, USA
    Circulation 113:67-73. 2006
    ..However, whether ECG strain is an independent predictor of new-onset congestive heart failure (CHF) in the setting of aggressive antihypertensive therapy in unclear...
  93. ncbi Gender differences in the treatment and secondary prevention of CHD at population level
    Anna Kattainen
    Department of Health and Functional Capacity, National Public Health Institute, Helsinki and Turku, Finland
    Scand Cardiovasc J 39:327-33. 2005
    ..The aim of this study was to investigate the state of treatment and secondary prevention of CHD in a population-based sample and to analyze possible gender differences in different age groups...
  94. ncbi Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s
    Anna Kattainen
    Department of Health and Functional Capacity, National Public Health Institute, Mannerheimintie 166, FI 00300 Helsinki, Finland
    Eur Heart J 27:296-301. 2006
    ..To analyse secular changes in the prevalence of coronary heart disease (CHD) and to assess changes in the burden of CHD at population level...
  95. ncbi Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy
    Michael H Olsen
    Department of Internal Medicine, Glostrup University Hospital, Glostrup, Denmark
    Am J Hypertens 18:1430-6. 2005
    ..We aimed to investigate whether they predicted cardiovascular (CV) events independently in patients with hypertension and electrocardiographic left ventricular (LV) hypertrophy...
  96. ncbi [Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)]
    Karl Swedberg
    Sahlgrenska Academy, , , Sweden
    Rev Esp Cardiol 58:1062-92. 2005
  97. ncbi Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study
    Kristian Wachtell
    Department of Medicine, Glostrup University Hospital, Glostrup, Denmark
    J Am Coll Cardiol 45:705-11. 2005
    ..We assessed the impact of antihypertensive treatment in hypertensive patients with electrocardiographic (ECG) left ventricular (LV) hypertrophy and a history of atrial fibrillation (AF)...